PERIODICAL
Marijuana legalization will be on the ballot in at least two U.S. states in November 2012, and it is the subject of serious debate in a growing number of countries. When it comes to understanding the consequences of legalization, the devil is in the details of how the regulatory regime is designed.
REPORT
Illicit drug use continues to be an important public health and safety concern in Europe. An evaluation of the EU Drugs Strategy 2005–12 and Action Plans examines the implementation, relevance, and influence of the Strategy and its added value for Member States and at EU level.
JOURNAL ARTICLE
Multiple dimensions of harm need to be displayed to inform human judgments of what drugs should be scheduled; recent efforts ignores drug interactions and mix aggregate and individual harms inappropriately.
PROJECT
To further analyze Europe's illicit drug market and the EU's responses to it, DPRC and RAND Europe are teaming with European partners to expand their original 2009 research on the global drug market.
JOURNAL ARTICLE
Having a greater knowledge of the amount of marijuana consumed and produced in each country will sustain substantially informed debates both sides of the border.
JOURNAL ARTICLE
Tener un mayor conocimiento sobre la cantidad de marihuana consumida y producida en cada país permitirá sostener debates sustancialmente informados a ambos lados de la frontera.
NEWS RELEASE
Efforts by the United States to combat Latin American cocaine smugglers have disrupted drug supplies and captured key cartel leaders, but they have not significantly reduced the region's overall narcotics trade.
REPORT
Efforts by the United States to combat Latin American cocaine smugglers have disrupted drug supplies and captured key cartel leaders, but they have not significantly reduced the region's overall narcotics trade.
REPORT
This study provides evidence on potential economic impact of policies designed to increase the price of alcoholic drinks on consumers, producers and retailers in the UK. Policy-makers used recommendations to implement a new pricing policy.
REPORT
In order to inform the European Commission's formal Impact Assessment for a revision to the Tobacco Products Directive, this study provides an overview of evidence for tobacco product regulation and an analysis of health and economic implications.
JOURNAL ARTICLE
This paper provides a look back at the creation, evolution and growth of the RAND Drug Policy Research Center (DPRC).
JOURNAL ARTICLE
This study provides descriptive information about 1,655 applicants in California who sought a physician's recommendation for medical marijuana, the conditions for which they sought treatment, and the diagnoses made by the physicians.
NEWS RELEASE
Legalizing marijuana in California will not dramatically reduce the drug revenues collected by Mexican drug trafficking organizations from sales to the United States.
RESEARCH BRIEF
Discusses whether legalizing marijuana in California would reduce the revenues of Mexican drug trafficking organizations and related violence.
REPORT
Testimony presented by Beau Kilmer before the California State Assembly Public Safety Committee and California State Senate Public Safety Committee on September 21, 2010.
NEWS RELEASE
Legalizing the production and distribution of marijuana in California could cut the price of the drug by as much as 80 percent and increase consumption.
REPORT
Legalizing the production and distribution of marijuana in California could cut the price of the drug by as much as 80 percent and increase consumption. While the state has estimated taxing legal marijuana could raise more than $1 billion in revenue, this could be dramatically higher or lower based on a number of factors.
RESEARCH BRIEF
Legalizing marijuana in California would lead to a substantial decline in price, but there is much uncertainty about legalization's effect on public budgets and consumption; even minor changes in assumptions lead to major differences in outcomes.
REPORT
In testimony presented before the House Oversight and Government Reform Committee, Subcommittee on Domestic Policy, Rosalie Liccardo Pacula speaks to the scientific evidence underlying drug policy initiatives in the FY2011 budget—including treatment, prevention, and enforcement strategies.
RAND® is a registered trademark. Copyright © 1994-2012 RAND Corporation. Last Modified: November 30, 2010 Site Feedback »